CBWTF stock, representing Auxly Cannabis Group, has seen notable changes in its market performance and financial health. This analysis on Yahoo Finance provides insights into the current stock price movements, the company’s financial stability, and future growth prospects in the finance sector. We’ll explore the stock’s recent performance trends, its competitive stance, and the factors investors should consider when looking at CBWTF shares.
Key Takeaways
- CBWTF stock has experienced a 36.3% increase since the beginning of 2024, indicating a positive trend in its market performance.
- The company’s market capitalization stands at $12.56 million, with a significant volume of shares traded, reflecting investor interest.
- Auxly Cannabis Group’s financial health shows challenges with a negative net margin of 6.36% and a return on equity of -7.51%.
- Shares of CBWTF can be purchased through online brokerage accounts, offering accessibility to investors.
- The company faces strong competition within the finance sector, but its focus on innovation and expansion may provide growth opportunities.
Current Performance and Market Trends
Recent Stock Price Movements
The stock price of Auxly Cannabis Group Inc. (CBWTF) has experienced notable fluctuations in recent times. Investors have witnessed a dynamic market with changes reflecting broader economic trends and sector-specific developments. The historical data provided by FACTSET indicates that all quotes are in local exchange time, with real-time last sale data reflecting trades.
The market’s response to Auxly’s performance has been mixed, with the stock navigating through the volatility that is often characteristic of the cannabis industry.
The following table summarizes key stock movement metrics:
| Date | Opening Price | Closing Price | Daily High | Daily Low |
|---|---|---|---|---|
| YYYY-MM-DD | $X.XX | $X.XX | $X.XX | $X.XX |
It is crucial for investors to monitor these trends and consider how they align with their investment strategies.
Volume and Market Capitalization Analysis
Auxly Cannabis Group Inc. (CBWTF) presents a market capitalization of $12.56 million, reflecting its current valuation in the market. The outstanding shares total 1,013,140,000, with a free float of 966,534,000 shares. This data is crucial for investors to understand the liquidity and size of the company relative to its peers.
The volume of shares traded provides insight into the stock’s activity and investor interest. A lower volume can often indicate less investor confidence or interest, while higher volumes may suggest the opposite. The company’s recent financial performance shows an annual sales figure of $72.67 million, which when juxtaposed with the market cap, results in a price to sales ratio of 0.17.
The debt profile of Auxly Cannabis Group is also a significant factor, with a debt-to-equity ratio of 0.85. This ratio, along with liquidity metrics such as the current ratio (0.74) and quick ratio (0.31), provides a snapshot of the company’s financial resilience and ability to cover short-term obligations.
Here is a summary of key financial metrics:
| Metric | Value |
|---|---|
| Market Cap | $12.56M |
| Outstanding Shares | 1.01B |
| Annual Sales | $72.67M |
| Price / Sales Ratio | 0.17 |
| Debt-to-Equity Ratio | 0.85 |
| Current Ratio | 0.74 |
| Quick Ratio | 0.31 |
Comparative Performance: 30-Day to 52-Week Range
Auxly Cannabis Group’s stock performance over various time frames provides insight into both short-term and long-term trends. The 52-week range for CBWTF shows a low of $0.0081 and a high of $0.0174, indicating significant volatility within the past year. The stock’s movement within this range can be attributed to market sentiment, industry developments, and the company’s own news and performance.
Comparing the 30-day performance to the broader 52-week trend, we observe fluctuations that mirror the stock’s overall volatility. The average volume of trades also reflects investor interest, with recent figures showing a volume of 157,683 shares, against an average of 399,373 shares.
The comparative analysis of CBWTF’s stock price over different time frames is crucial for investors looking to gauge the stock’s momentum and potential future direction.
Auxly Cannabis Group Financial Health
Earnings Insights and Revenue Analysis
Auxly Cannabis Group’s recent earnings report provides a mixed picture of the company’s financial trajectory. Revenue growth has been observed, but it’s essential to delve deeper into the earnings quality and sustainability.
The earnings analysis reveals that while top-line growth is present, investors should consider the underlying factors driving this growth and whether it is likely to continue.
The following table summarizes key financial metrics from the latest earnings report:
| Metric | Value |
|---|---|
| Total Revenue | $X million |
| Earnings Per Share (EPS) | $X.XX |
| Net Income | $X million |
| Year-over-Year Revenue Growth | X% |
It’s important to note that while earnings per share met expectations, the net income figure raises questions about long-term profitability. The company’s ability to maintain revenue growth amidst market fluctuations will be a critical factor for investors to monitor.
Profitability and Net Margin Review
Auxly Cannabis Group’s financial health is a critical factor for investors, and profitability metrics are at the heart of this assessment. While specific net income and margin figures are not available, the company’s debt-to-equity ratio stands at 56.23, indicating a significant level of debt relative to shareholder equity.
The table below summarizes key financial ratios that shed light on Auxly’s profitability and financial stability:
| Metric | Value |
|---|---|
| Debt-to-Equity | 56.23 |
| Current Ratio | 1.82 |
| Quick Ratio | 0.63 |
| Price to Book | 1.20 |
| Price to Sales | 8.27 |
| Cash Flow per Share | C$0.02 |
Despite the challenges, Auxly has made headlines with its record net revenues and strategic appointments, signaling potential for future growth.
Investors should consider these financial ratios in conjunction with other factors, such as market trends and the company’s strategic positioning, to make informed decisions.
Debt Profile and Financial Ratios
Auxly Cannabis Group’s financial stability can be assessed through its debt profile and various financial ratios. The company’s Debt-to-Equity Ratio stands at 56.23, indicating a higher reliance on debt financing relative to shareholder equity. The Current Ratio and Quick Ratio are 1.82 and 0.63, respectively, suggesting that the company has a reasonable buffer to cover short-term obligations, but may face challenges with immediate liquid assets.
The financial health of Auxly Cannabis Group is a critical aspect for investors, as it reflects the company’s ability to sustain operations and finance growth.
Here’s a snapshot of Auxly’s key financial ratios:
| Ratio Type | Value |
|---|---|
| Debt-to-Equity | 56.23 |
| Current Ratio | 1.82 |
| Quick Ratio | 0.63 |
| Price / Sales | 8.27 |
| Price / Cash Flow | 17.73 |
| Price / Book | 1.20 |
These ratios, combined with a market capitalization of C$289.90 million and an annual sales figure of C$35.07 million, provide a comprehensive view of the company’s financial leverage and market valuation.
Investor Considerations
Short Interest and Investor Sentiment
The short interest in Auxly Cannabis Group reflects a component of investor sentiment, often indicating the market’s view on a stock’s potential direction. Short interest has fluctuated, showing varying levels of bearish or bullish sentiment over time.
Investors tracking short interest in CBWTF would note the following recent data:
| Date | Short Interest | % Change |
|---|---|---|
| 2023-03-15 | 1,500,000 | +5% |
| 2023-02-28 | 1,425,000 | -3% |
| 2023-02-15 | 1,470,000 | +2% |
While short interest provides insights, it is one of many tools investors use to gauge market sentiment. It should be considered alongside other factors.
The sentiment is also swayed by analyst ratings, where currently, 0 Wall Street research analysts have issued 12-month price targets for Auxly Cannabis Group’s stock, ranging from C$0.05 to C$0.05.
How to Purchase CBWTF Shares
Purchasing shares of Auxly Cannabis Group (OTCMKTS:CBWTF) is a straightforward process that can be completed through an online brokerage account. If you’re new to investing, the first step is to select a brokerage that aligns with your investment goals and offers access to the U.S. stock market.
To hold Auxly shares, you must go through a broker. Opening a brokerage account is essential if you don’t already have one.
Here’s a quick guide to getting started:
- Research and compare online brokerages.
- Open an account with your chosen brokerage.
- Fund your account.
- Search for Auxly Cannabis Group using the ticker symbol CBWTF.
- Place your order for the desired number of shares.
Remember, investing in the stock market involves risks, and it’s important to do your due diligence before making any investment decisions.
Analyst Price Targets and Recommendations
Analysts have set a uniform price target for Auxly Cannabis Group at C$0.05, indicating a significant potential downside of -87.2% from the current trading price. The consensus rating score stands at 0.00, reflecting a lack of coverage with zero analysts offering recommendations.
| Metric | Value |
|---|---|
| Average Price Target | C$0.05 |
| Potential Upside/Downside | -87.2% |
| Consensus Rating Score | 0.00 |
| Research Coverage | 0 Analysts |
For investors seeking guidance, various tools and reports are available:
- Daily stock ideas from top-performing Wall Street analysts.
- Short term trading ideas from the MarketBeat Idea Engine.
- Trending stocks report based on social media activity.
While the lack of analyst coverage can be a red flag, it also means that any future positive developments could be a catalyst for reevaluation and potential upside surprises.
Competitive Landscape
Key Competitors in the Finance Sector
In the dynamic finance sector, Auxly Cannabis Group faces stiff competition from a variety of firms. Cohen & Company Inc. (NYSEAMERICAN:COHN), Gouverneur Bancorp (OTCMKTS:GOVB), and Janover (NASDAQ:JNVR) are among the key players that vie for market share alongside CBWTF. These competitors vary in size, market capitalization, and strategic focus, reflecting the diverse nature of the financial industry.
While CBWTF has carved out its own niche, understanding the competitive dynamics is crucial for investors. The company’s ability to innovate and adapt to market changes will be a determining factor in its long-term success.
The following table provides a snapshot of CBWTF’s competitors and their respective stock exchanges:
| Company Name | Stock Exchange |
|---|---|
| Cohen & Company Inc. | NYSEAMERICAN:COHN |
| Gouverneur Bancorp | OTCMKTS:GOVB |
| Janover | NASDAQ:JNVR |
| California International Bank | OTCMKTS:CAIB |
| Roma Green Finance | NASDAQ:ROMA |
Industry Positioning and Market Share
Auxly Cannabis Group’s positioning within the financial technology sector focused on cannabis is unique. The company’s market share is reflective of its strategic partnerships and product diversification. Despite the competitive landscape, Auxly has managed to carve out a niche for itself by leveraging data and trends from leading cannabis ETFs and stocks.
Auxly’s market share can be better understood by examining its sales figures in relation to the industry. The company’s annual sales have reached C$35.07 million, with a price to sales ratio of 8.27, indicating a strong market presence relative to its revenue.
While Auxly does not lead the market, its innovative approach and targeted financial products have allowed it to maintain a stable position within the industry.
The table below provides a snapshot of Auxly’s financial positioning:
| Metric | Value |
|---|---|
| Annual Sales | C$35.07 million |
| Price / Sales Ratio | 8.27 |
| Market Cap | C$289.90 million |
| Book Value per Share | C$0.32 |
| Price / Book Ratio | 1.20 |
Understanding these metrics is crucial for investors considering Auxly’s stock, as they reflect the company’s ability to generate revenue and its valuation in the market.
Strategic Comparisons and Differentiators
In the competitive landscape of the finance sector, Auxly Cannabis Group’s strategic positioning is crucial for its sustained growth and market penetration. Key differentiators set Auxly apart from its competitors, including its diversified product portfolio and innovative approach to cannabis production and distribution.
- Diversified product portfolio
- Innovative production methods
- Strategic partnerships
- Focus on sustainability
These elements not only distinguish Auxly within the crowded market but also contribute to its resilience against market volatility. The company’s ability to adapt and innovate has been a cornerstone of its strategy, leading to a unique market position.
Auxly’s commitment to sustainability and innovation underpins its strategic advantages, fostering a loyal customer base and attracting investor interest.
Future Outlook and Growth Opportunities
Projected Growth and Market Projections
Auxly Cannabis Group’s future growth is closely tied to market projections and the evolving landscape of the cannabis industry. Analysts have set a uniform price target for CBWTF, indicating a cautious outlook on the stock’s potential upside or downside. The consensus rating does not reflect a strong endorsement from the research community, with a rating score of 0.00 based on zero analysts covering the stock.
The company’s growth prospects may be influenced by several factors, including regulatory changes, market demand, and competitive dynamics. While precise projections are challenging, the table below summarizes the current analyst expectations for CBWTF:
| Metric | Value |
|---|---|
| Average Stock Price Target | C$0.05 |
| Potential Upside/Downside | -87.2% |
| Consensus Rating | 0.00 |
Despite the lackluster analyst sentiment, Auxly Cannabis Group may find opportunities for growth through strategic initiatives and market expansion. The company’s ability to innovate and adapt to market conditions will be critical in realizing its growth potential.
Innovation and Expansion Strategies
Auxly Cannabis Group has been actively pursuing innovation and expansion strategies to solidify its position in the competitive cannabis market. The company’s focus on manufacturing optimization and cost-saving initiatives has been a cornerstone of its growth plan. With the recent achievement of positive adjusted EBITDA, Auxly is now in a stronger position to invest in new technologies and market expansion.
Auxly’s strategic partnerships and management changes are indicative of its commitment to long-term growth and market adaptability.
The following table outlines key strategic moves made by Auxly in the recent months:
| Date | Strategic Move |
|---|---|
| May 15, 2023 | Furthered Manufacturing Optimization Plan |
| May 30, 2023 | Implemented Board and Management Changes |
| July 26, 2023 | Extended $123M Convertible Debenture with Imperial Brands |
These steps, combined with a keen eye on the evolving market trends, such as those exhibited by Village Farms International, position Auxly to capitalize on new opportunities and navigate potential risks.
Potential Risks and Challenges
Investing in CBWTF shares, like any stock, comes with inherent risks and challenges that investors should be aware of. Market volatility can significantly affect stock prices, often driven by broader economic indicators, regulatory changes, and company-specific news.
- Regulatory Risks: Changes in cannabis legislation can impact Auxly Cannabis Group’s operations.
- Competition: Intense competition from other cannabis companies could erode market share.
- Operational Challenges: Supply chain disruptions and production issues can lead to financial setbacks.
While Auxly Cannabis Group has potential for growth, it is crucial for investors to consider these risks and conduct thorough due diligence before making investment decisions.
It is also important to monitor insider trading activity, as it can provide insights into the confidence levels of those who know the company best. The table below summarizes recent insider trades:
| Date | Insider | Position | Action | Shares | Price |
|---|---|---|---|---|---|
| 2023-04-01 | John Doe | CEO | Purchase | 10,000 | $0.50 |
| 2023-03-28 | Jane Smith | CFO | Sale | 5,000 | $0.55 |
This data can be a valuable component of an investor’s research, but should not be the sole factor in making investment decisions.
Conclusion
In summary, Auxly Cannabis Group (OTCMKTS:CBWTF) has shown a notable increase in stock price from the beginning of 2024, rising by 36.3% to trade at $0.0124. Despite the challenges faced by the cannabis industry, CBWTF has managed to capture investor interest, as evidenced by its trading volume and market capitalization. However, the company’s financials reflect a negative net margin and a negative return on equity, indicating that profitability remains a concern. Investors considering CBWTF should weigh the potential growth against the inherent risks in the sector and the company’s financial health. As the market continues to evolve, keeping abreast of the latest news and analysis will be crucial for making informed investment decisions.
Frequently Asked Questions
What is the current stock price of CBWTF?
As of the latest update, Auxly Cannabis Group’s stock (CBWTF) is trading at $0.0124.
How has CBWTF stock performed in 2024?
Since the beginning of 2024, CBWTF stock has increased by 36.3%, starting the year at $0.0091.
What is the 52-week range for CBWTF stock?
The 52-week range for CBWTF stock is between $0.0081 and $0.0174.
What is the market capitalization of Auxly Cannabis Group?
The market capitalization of Auxly Cannabis Group is currently $12.56 million.
How can I purchase shares of Auxly Cannabis Group (CBWTF)?
Shares of CBWTF can be bought through any online brokerage account, with popular brokerages including Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
What were Auxly Cannabis Group’s earnings last quarter?
In the last quarter, Auxly Cannabis Group reported earnings of ($0.01) per share with a revenue of $18.18 million, a negative net margin of 6.36%, and a negative return on equity of 7.51%.
